Early research (Phase 1)Study completedNCT00293488What this trial is testingSL-11047 in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forLymphoma Progen Pharmaceuticals 20
Testing effectiveness (Phase 2)Looking for participantsNCT07249905What this trial is testingDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaWho this might be right forLymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more ModeX Therapeutics, An OPKO Health Company 180
Testing effectiveness (Phase 2)Ended earlyNCT05896163What this trial is testingLearn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.Who this might be right forDiffuse Large B-Cell Lymphoma Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT02564744What this trial is testingStudy to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHLWho this might be right forDiffuse Large B-Cell LymphomaB-cell Non-Hodgkin's Lymphoma Debiopharm International SA 100
Early research (Phase 1)Active Not RecruitingNCT04007029What this trial is testingModified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forCD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more Jonsson Comprehensive Cancer Center 24
Early research (Phase 1)Ended earlyNCT03886649What this trial is testingCopanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.Who this might be right forNon-Hodgkin Lymphoma Swiss Cancer Institute 7
Early research (Phase 1)Active Not RecruitingNCT05753501What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesWho this might be right forHematologic Cancer AbbVie 135
Testing effectiveness (Phase 2)Ended earlyNCT00543582What this trial is testingMGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin LymphomaWho this might be right forHodgkin LymphomaNon-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma) Mirati Therapeutics Inc. 23
Testing effectiveness (Phase 2)WithdrawnNCT03586024What this trial is testingPembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell LymphomasWho this might be right forLymphoma Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)UnknownNCT01435720What this trial is testingSafety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)Who this might be right forMultiple MyelomaMultiple Myeloma in RelapseMantle Cell Lymphoma in Relapse+3 more Senesco Technologies, Inc. 15
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Study completedNCT00062296What this trial is testingEpirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT02226965What this trial is testingPNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)Who this might be right forLymphoma, Diffuse Large B-Cell Sierra Oncology LLC - a GSK company 45
Testing effectiveness (Phase 2)Ended earlyNCT02361346What this trial is testingSafety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCLWho this might be right forNon-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic Leukemia+3 more Molecular Templates, Inc. 38
Testing effectiveness (Phase 2)WithdrawnNCT04456023What this trial is testingStudy of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma (DLBCL) Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06299553What this trial is testingStudy to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)Who this might be right forDLBCL - Diffuse Large B Cell Lymphoma Incyte Biosciences Italy S.r.l 200
Not applicableStudy completedNCT04981795What this trial is testingRealMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B-cell Lymphoma Incyte Corporation 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05950165What this trial is testingAssess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin Lymphoma Cho Pharma Inc. 37
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00098566What this trial is testingLong-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaQuality of Life Fred Hutchinson Cancer Center 36